Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2025 Jun;64(2):e70041.
doi: 10.1111/famp.70041.

Evaluation of the Health-Related Quality of Life and Mental Health of Parents With Children and Adolescents With a Rare Disease Based on the Results of a Randomized Controlled Trial to Investigate a Family-Based Intervention and an Online Intervention for Affected Families (CARE-FAM-NET)

Affiliations
Randomized Controlled Trial

Evaluation of the Health-Related Quality of Life and Mental Health of Parents With Children and Adolescents With a Rare Disease Based on the Results of a Randomized Controlled Trial to Investigate a Family-Based Intervention and an Online Intervention for Affected Families (CARE-FAM-NET)

Antonia Steinberg et al. Fam Process. 2025 Jun.

Abstract

Parents caring for children with rare diseases are more impaired regarding health-related quality of life (HRQoL) and mental health than healthy controls and norm data. To address the research gap in psychological care for these parents, this study evaluates the effectiveness of two family-based interventions. The children affected by rare disease and their families network (CARE-FAM-NET) study is a multicenter randomized controlled 2 × 2 factorial trial for affected families with children (0-21 years). This paper focuses on evaluating the impact of two interventions, one face-to-face (CARE-FAM) and one online (WEP-CARE), on the HRQoL and mental health of parents. One thousand, one hundred sixty-eight parents participated: TAU = 291, CARE-FAM = 296, WEP-CARE = 300, and CARE-FAM + WEP-CARE combined = 281. Data were collected at four time points over a period of 18 months using standardized questionnaires. The results had to be interpreted exploratively. The results indicate that there are no clinically relevant differences in the parents' HRQoL and mental health between the treatment groups. However, time-dependent differences in the intervention effects for WEP-CARE were observed. Although the results did not show clear relevant differences between conditions, trends in improvement in HrQoL and mental health were identified. CARE-FAM shows a greater reduction in parental distress and WEP-CARE shows a greater distortion of distress, particularly at T3 and T4. Given the exploratory nature of this study, it highlights the urgent need for further confirmatory research in this area.

Keywords: family intervention; health‐related quality of life; mental health; parents; rare disease.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Description of the study population, number of randomized participants, allocation to three intervention groups (CARE‐FAM, WEP‐CARE, CARE‐FAM + WEP‐CARE) and one control group (TAU). Numbers of participants at every measurement point after 6, 12, and 18 m. “Family missing” indicated that the entire family did not provide any information at that time.

Similar articles

References

    1. Baumbusch, J. , Mayer S., and Sloan‐Yip I.. 2018. “Alone in a Crowd? Parents of Children With Rare Diseases' Experiences of Navigating the Healthcare System.” Journal of Genetic Counseling 28: 80–90. 10.1007/s10897-018-0294-9. - DOI - PubMed
    1. Boettcher, J. , Boettcher M., Wiegand‐Grefe S., and Zapf H.. 2021. “Being the Pillar for Children With Rare Diseases—A Systematic Review on Parental Quality of Life.” International Journal of Environmental Research and Public Health 18, no. 9: 4993. 10.3390/ijerph18094993. - DOI - PMC - PubMed
    1. Boettcher, J. , Filter B., Denecke J., et al. 2020. “Evaluation of Two Family‐Based Intervention Programs for Children Affected by Rare Disease and Their Families—Research Network (CARE‐FAM‐NET): Study Protocol for a Rater‐Blinded, Randomized, Controlled, Multicenter Trial in a 2 × 2 Factorial Design.” BMC Family Practice 21, no. 1: 239. 10.1186/s12875-020-01312-9. - DOI - PMC - PubMed
    1. Boettcher, J. , Nazarian R., Fuerboeter M., et al. 2022. “Mental Health of Siblings of Children With Rare Congential Surgical Diseases During the COVID‐19 Pandemic.” European Journal of Pediatric Surgery 32, no. 5: 422–428. 10.1055/s-0041-1740978. - DOI - PubMed
    1. Candy, B. , Jones L., Drake R., Leurent B., and King M.. 2011. “Interventions for Supporting Informal Caregivers of Patients in the Terminal Phase of a Disease.” Cochrane Database of Systematic Reviews 6: Cd007617. 10.1002/14651858.CD007617.pub2. - DOI - PubMed

Publication types

Grants and funding

LinkOut - more resources